Latest revenue
$2.1M
as of 2026-03-31
Latest net income
$-6.9M
as of 2026-03-31
Net margin
-321.6%
as of 2026-03-31
Price
Price history unavailable for EKSO.
Market data
Price feed temporarily unavailable for EKSO.
5-year trend
What this company does
Item 1. BUSINESS Company Background Founded in 2005, we are a Nevada corporation that designs, develops, and markets exoskeleton products that augment human strength, endurance and mobility. The primary end market for our exoskeleton technology is healthcare, where our technology primarily serves people with physical disabilities or impairments in both physical rehabilitation and mobility. The majority of our sales are generated from our Enterprise Health products, which includes the sales of products and services related to neurorehabilitation in clinical settings. We also provide products and services from our Personal Health market to individual users. In addition to our current products…
AI summary unavailable — showing raw filing excerpt
Generated from EKSO's filing dated 2026-02-23
Key risks
Item 1A. RISK FACTORS Investing in our common stock involves a high degree of risk. You should carefully consider the risks and uncertainties described below, together with all of the other information in this Annual Report on Form 10-K including the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our consolidated financial statements and related notes, before making a decision to invest in our common stock. Our business, results of operations, financial condition or prospects could also be harmed by risks and uncertainties that are not presently known to us or that we currently believe are not material. If any of the risks actually…
AI summary unavailable — showing raw filing excerpt
Generated from EKSO's filing dated 2026-02-23
Profitability
Gross margin
53.5%
0.8%Operating margin
-104.1%
78.4%Net margin
-91.4%
44.6%Return on equity
-129.6%
45.3%Return on assets
-58.2%
36.8%Leverage
Debt / equity
1.23×
11.9%Long-term debt / equity
0.09×
70.9%Debt / assets
55.1%
5.3%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $2.1M | -36.6% | $-6.9M | -138.2% | -321.6% |
Q4 2025 2025-12-31 | $3.1M | -38.3% | $-4.7M | -36.9% | -148.9% |
Q3 2025 2025-09-30 | $4.2M | +2.4% | $-1.4M | +31.4% | -33.6% |
Q2 2025 2025-06-30 | $2.1M | -58.4% | $-2.7M | -12.1% | -131.7% |
Q1 2025 2025-03-31 | $3.4M | -10.1% | $-2.9M | +15.7% | -85.7% |
Q4 2024 2024-12-31 | $5.1M | — | $-3.4M | — | -67.1% |
Q3 2024 2024-09-30 | $4.1M | -10.4% | $-2.1M | +38.4% | -50.2% |
Q2 2024 2024-06-30 | $5.0M | +5.3% | $-2.4M | +42.9% | -48.8% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
General Industrial Machinery & Equipment, NEC · SIC 3569
Your notes
Keep private notes on EKSO — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$1.2M
Insider selling
$232.1K
Net activity
+$971.7K
Distinct insiders
4
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns EKSO
Institutional value
$5.4M
Total shares held
505.2K
Distinct holders
16
-11 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | DBA TRADING, LLC | 270.4K | $2.9M | +113.7K (+72.5%) | Added |
| 2 | Mink Brook Asset Management LLC | 95.3K | $1.0M | — | New |
| 3 | Vontobel Holding Ltd. | 52.9K | $563.7K | — | New |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 34.0K | $362.4K | — | New |
| 5 | SEI INVESTMENTS CO | 25.6K | $272.7K | — | New |
| 6 | VANGUARD FIDUCIARY TRUST CO | 16.8K | $178.9K | — | New |
| 7 | BlackRock, Inc. | 3.6K | $38.9K | +0 (+0.0%) | No change |
| 8 | Compagnie Lombard Odier SCmA | 1.7K | $17.7K | +0 (+0.0%) | No change |
| 9 | Golden State Wealth Management, LLC | 1.3K | $13.8K | +0 (+0.0%) | No change |
| 10 | UBS Group AG | 1.0K | $10.9K | +1.0K (+34033.3%) | Added |
| 11 | MTM Investment Management, LLC | 39 | $415 | +0 (+0.0%) | No change |
| 12 | SBI Securities Co., Ltd. | 20 | $213 | +0 (+0.0%) | No change |
| 13 | VISION FINANCIAL MARKETS LLC | 6 | $64 | +0 (+0.0%) | No change |
| 14 | Roble, Belko & Company, Inc | 2.3K | $25 | +1.2K (+104.5%) | Added |
| 15 | Redwood Park Advisors LLC | 2 | $22 | +0 (+0.0%) | No change |
| 16 | Steward Partners Investment Advisory, LLC | 1 | $11 | +0 (+0.0%) | No change |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once EKSO's latest filing finishes processing.